Biomarkers and Cancer Targets

Biomarkers or the molecular markers are the biological molecules (such as DNA, RNA, and Proteins), genes or the processes such as apoptosis and proliferation by which a specific disease, condition or any abnormalities in the body can be identified. It is a measurable indicator in a biological system and can be found in blood, tissues, specific organs, cell lines and in other body fluids.

They play a major role in the diagnosis as well as for the management of CancerCancer biomarkers are either produced by the tumors itself or in response to the disease or other associated factors such as inflammation, indicating the presence of the Cancer in the body.

Biomarkers are primarily used in three ways for Cancer research and medicine:

  • Diagnostic (or screening) biomarker: For the diagnosis of the condition, as in the case of an early stage of the Cancer.
  • Prognostic biomarker: forecasting of the condition that how aggressive it is and determining the patient’s response in the absence of the treatment.
  • Stratification (predictive) biomarker: to predict the patient’s response to the treatment.

    Related Conference of Biomarkers and Cancer Targets

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Biomarkers and Cancer Targets Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in